Skip to main content

Find Clinical Trials

Home
Conditions
Mycosis Fungoides

Clinical trial condition

Mycosis Fungoides

Explore clinical trials studying Mycosis Fungoides. Study availability and eligibility vary by location and protocol.

308 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

Mycosis Fungoides trial results

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

NCT00255710

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00005580

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations: New York Presbyterian Hospital - Cornell Campus New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

NCT00050999

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States

Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia

Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia

Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia

View all 35 locations

View Trial Details

Completed

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

NCT00051012

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States

Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia

Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia

Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia

View all 34 locations

View Trial Details

Completed

Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

NCT00306969

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Boston University Medical Center Boston, Massachusetts, United States

View Trial Details

Suspended

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

NCT02702310

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details